... Biotechnology ATOS ... The data is being presented in a poster at the 2024 San Antonio Breast Cancer Symposium (SABCS) on December 13, 2024.
News
- Atossa Therapeutics to Present Poster Describing the Discovery o - GuruFocus
- bioAffinity Technologies Set for Continued Expansion in 2025 | News | bakersfield.com
SAN ANTONIO--(BUSINESS WIRE)--Dec 12, 2024--. bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need ...
- Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in ... - BioSpace
... San Antonio Breast Cancer Symposium. December ... Celcuity is a clinical-stage biotechnology ... Vector Illustration of pharmacy drug health tablet ...
- Ibrance combination extends median PFS in breast cancer group | The Pharmaletter
12 December 2024. More on this story... Pfizer's rollercoaster ride and what comes next · Biotechnology.
- TerSera® Presents New Real-World Evidence on Treatment Outcomes of Goserelin ... - BioSpace
These data were presented in a poster session at the 2024 San Antonio Breast Cancer Symposium, held December 10-13 in San Antonio, TX.1 A copy of ...